MedTech News
WAT Medical wins FDA nod for OTC migraine preventative device
HeadaTerm 2 uses neuromodulation technology. It releases targeted electrical impulses that increase the pain tolerance of the wearer.
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
The Venus Versa Pro combines the applicator of the Venus Viva MD with the Venus Versa system which are both approved in Australia and registered in Australian Register of Therapeutic Goods (ARTG).
Affinity Biosensors Receives FDA Clearance for the LifeScale AST System
This milestone gives healthcare professionals an important tool for managing bacteremia by providing antibiotic susceptibility test (AST) results with unprecedented speed.
NHS begins rollout of artificial pancreas in ‘world first’ move
“This really is a landmark moment and we’ll be working with the NHS and others to ensure a fair rollout that reaches people as quickly as possible.”
Olympus wins FDA clearance for its first single-use flexible ureteroscope
Benefits of the system, according to a news release, include maneuverability and visualization.
Baxter receives FDA clearance for delayed Novum IQ infusion pump
The clearance ends a three-year back-and-forth with the FDA to get the product to market.
HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device
Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users. It is FDA-cleared for the preventative treatment of migraine headaches.
Drawbridge secures FDA 510(k) Clearance for At-Home Blood Sampling Device NanoDrop
NanoDrop is the First Over-the-Counter Blood-Lancing Device Labeled for the Upper Arm to be Cleared in the United States, Changing the Landscape of the At-Home Consumer Testing Market and Decentralized Clinical Trials